Stay updated on Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag updated from v3.6.2 to v3.6.3, signaling a small update to the page rather than a change to the study information.SummaryDifference0.0%

- Check9 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a version update to the page content. This likely reflects minor edits or updates to the page's metadata or formatting.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page gained new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows updated recruitment messaging (No longer looking for participants). A heading label change from 'Intervention / Treatment' to 'Intervention/Treatment' and an updated site revision tag (Revision: v3.6.0) are also present.SummaryDifference0.4%

- Check30 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5. This reflects a new version of the page and does not appear to change study data or visible content.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page's revision number was updated from v3.5.3 to v3.5.4, indicating a minor backend/template update that does not change the displayed study details.SummaryDifference0.1%

- Check72 days agoChange DetectedThis updates the ClinicalTrials.gov page’s display revision/version in the footer from v3.5.2 to v3.5.3, without changing any study details or record information.SummaryDifference0.0%

Stay in the know with updates to Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.